-
Mashup Score: 0
The FDA decided a New Drug Application lacked sufficient data to approve tebipenem pivoxil hydrobromide (tebipenem HBr) for the treatment of patients with complicated urinary tract infection.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0
The FDA is evaluating a new drug application for oral tebipenem pivoxil hydrobromide for the treatment of patients with complicated urinary tract infection, including acute pyelonephritis.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Investigational oral agent noninferior to intravenous ertapenem for complicated UTIs - 2 year(s) ago
“Oral tebipenem pivoxil hydrobromide and intravenous ertapenem had a similar safety and tolerability profile,” says Angela Talley, MD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 5Daily Sublingual Therapy Cuts UTI Recurrences by More Than Half - 2 year(s) ago
A collection of inactivated bacteria, given sublingually for three months, can dramatically reduce the risk of urinary-tract infection in women who have recurrent episodes.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1
Using point-of-care urine testing as an alternative to urine microscopy significantly reduced pediatric ED length of stay and time from urinalysis order to discharge order.
Source: PubMedCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 4
“We were able to show that there was a very…clinically significant decrease in the rate of UTIs in the vaccinated group, preventing UTIs in almost 60% of vaccinated patients,” says J. Curtis Nickel, MD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0
“We were able to show that there was a very…clinically significant decrease in the rate of UTIs in the vaccinated group, preventing UTIs in almost 60% of vaccinated patients,” says J. Curtis Nickel, MD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Novel MV140 vaccine is “game changing” for recurrent UTIs - 3 year(s) ago
“We have the rising spectra of national and international antibiotic resistance, which is becoming a huge international medical issue,” says J. Curtis Nickel, MD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Novel MV140 vaccine is “game changing” for recurrent UTIs - 3 year(s) ago
“We have the rising spectra of national and international antibiotic resistance, which is becoming a huge international medical issue,” says J. Curtis Nickel, MD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0What can be learned from a clinical trial of standard vs expanded cultures to diagnose UTI - 3 year(s) ago
“What was surprising to us was that in both arms, about a third of the women really didn’t have a urinary tract infection,” says Elizabeth R. Mueller, MD, MSME.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
FDA says oral UTI treatment application is insufficient for approval https://t.co/1GgC4BDz4M #FDA #urology #urologist #urinarytractinfection